EDSA up 21% ...next milestone is the ACD Phase 2b readout coming within 8 weeks ... Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study https://www.streetinsider.com/Accesswire/Edesa+Biotech+Reports+Statistically+Significant+Mortality+Reductions+in+Phase+2+ARDS+Drug+Study/20647965.html